Related Experiment Video

Updated: Aug 21, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

[The effectiveness of latanoprost for the treatment of pediatric glaucoma]

Beata Urban1, Alina Bakunowicz-Lazarczyk, Małgorzata Mrugacz

  • 1Kliniki Okulistyki Dzieciecej Akademii Medycznej w Białymstoku.

Klinika Oczna
|October 30, 2004
PubMed

Insights

Latanoprost effectively lowers intraocular pressure in children with various types of glaucoma. This study found mild ocular side effects, suggesting a favorable safety profile for pediatric glaucoma management.

Area of Science:

  • Ophthalmology
  • Pharmacology

Background:

  • Latanoprost, a prostaglandin F2alpha analog, is a well-established treatment for reducing intraocular pressure (IOP) in adults with open-angle glaucoma.
  • Limited data exists on the efficacy and safety of latanoprost in pediatric populations.

Purpose of the Study:

  • To evaluate the effect of latanoprost on intraocular pressure in children with different forms of glaucoma.
  • To assess the safety and tolerability of latanoprost in this pediatric cohort.

Main Methods:

  • A study was conducted on 14 children (aged 12-18 years) with glaucoma.
  • Patients were divided into two groups: juvenile glaucoma and secondary glaucoma (due to uveitis, aniridia, albinism).
  • Intraocular pressure reduction and ocular side effects were monitored.

Main Results:

  • In the juvenile glaucoma group, latanoprost achieved an average IOP reduction of 9 mmHg (36.5%).
  • In the secondary glaucoma group, the average IOP reduction was 6.5 mmHg (23.5%).
  • One child with aniridia required surgery after IOP increased post-treatment; other ocular side effects were mild.

Conclusions:

  • Latanoprost demonstrates significant efficacy in reducing intraocular pressure in children with juvenile and secondary glaucoma.
  • The medication appears to have a favorable safety profile with mild ocular side effects in pediatric patients.
  • Further research may be warranted to optimize treatment duration and identify potential long-term challenges.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...